-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

602.P1.34 602. Myeloid Oncogenesis: Basic: Poster I

Symposia: Myeloid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Michael H. Kramer, MD, PhD1, Stephanie N Richardson2*, Yang Li, MD PhD2*, Tiankai Yin, BA2, Nichole Helton2*, Daniel George2*, Michelle Cai, MD2*, Sai Mukund Ramakrishnan, MS2*, Christopher A Miller, PhD2* and Timothy J Ley, MD2

1Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO
2Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

Michael S Bowman, PhD1*, Maria A. Telpoukhovskaia, PhD2*, Jennifer J. Trowbridge, PhD2 and Robert L. Bowman, PhD1

1Department of Cancer Biology, University of Pennsylvania School of Medicine, Philadelphia, PA
2The Jackson Laboratory, Bar Harbor, ME

Neetij Krishnan1*, Stephanie Crowley1, Lynn S. White1*, Wei Yang, PhD2*, Jeffrey A. Magee, MD, PhD1 and Jeffrey J. Bednarski, MD, PhD1

1Department of Pediatrics, Division of Hematology/Oncology, Washington University School of Medicine, Saint Louis, MO
2Department of Genetics, Washington University School of Medicine, Saint Louis, MO

Monica Nathan, BS1*, Ahmed Mahmoud, MD2*, Nancy BJ Arthur, PhD2, Agata Gruszczynska3*, Stephen Sykes, PhD4 and Francesca Ferraro, MD, PhD5

1Internal Medicine, Oncology, Washington Univeristy in Saint Louis, Saint Louis, MO
2Department of Internal Medicine, Division of Oncology, Washington University of Saint Louis, School of Medicine, Saint Louis
3Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
4Department of Pediatrics, Washington University School of Medicine, St Louis, MO
5Department of Internal Medicine, Division of Oncology, Washington University of Saint Louis, School of Medicine, SAINT LOUIS, MO

Qiong Wu, PhD1*, Chunjie Yu, PhD1*, Fang Yu, PhD1*, Yiran Guo, PhD2*, Yue Sheng, PhD3, Liping Li, MD4*, Yafang Li, PhD1*, Yutao Zhang3*, Chao Hu, MD5*, Jue Wang, PhD1*, Tong-Chuan He, PhD6*, Yong Huang, PhD7*, Hongyu Ni, MD8, Zhigang Hou, PhD9*, Wenshu Wu, PhD5*, Greg G Wang, PhD10*, Jianxin Lyu, PhD11* and Zhijian Qian1

1Division of Hematology/Oncology, Department of Medicine and Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL
2Department of Pharmacology and Cancer Biology, Duke University, Durham, NC
3Division of Hematology/Oncology, Department of Medicine and Department of Biochemistry and Molecular Biology, University of Florida, Gainesville
4Department of Pathology at Geisinger Medical Center, Danville
5University of Illinois at Chicago, Chicago
6University of Chicago, Chicago
7University of Virginia, Charlottesville
8Cedars Sinai Medical Center, Los Angeles, CA
9Department of Biostatistics, University of Florida, Gainesville
10Department of Pharmacology and Cancer Biology, Duke University, Durham
11People's Hospital of Hangzhou Medical College, Hangzhou, CHN

Hongwei Peng1*, Wan Jiaqi1*, Jinfang Hu2*, Fei Li3,4,5 and Xintong Yang6*

1Nanchang University, Nanchang, China
2Department of Pharmacy, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
3First Affiliated Hospital of Nanchang University, Nanchang, China
4Department of Hematology, Jiangxi Clinical Research Center for Hematologic Disease, Jiangxi Provincial Key Laboratory of Hematological Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang, Jiangxi Province, China
5Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
6School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, China

Josephine Jagd Brysting1,2*, Christian Rohde, PhD3,4*, Laura Villacorta5*, Vladimir Benes6*, Simon Renders, MD7,8*, Judith Zaugg9* and Carsten Müller-Tidow, MD8,10*

1Molecular Medicine Partnership Unit, European Molecular Biology Laboratory (EMBL), University of Heidelberg, Heidelberg, Germany
2Department of Internal Medicine V, Hematology, Rheumatology, Oncology, University Hospital Heidelberg, Heidelberg, AL, Germany
3Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
4Molecular Medicine Partnership Unit, European Molecular Biology Lab (EMBL), Heidelberg, Germany
5Genomic Core Facility, European Molecular Biology Laboratories, Heidelberg, Heidelberg, Germany
6Genomic Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany
7Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany
8Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
9Molecular Medicine Partnership Unit, European Molecular Biology Laboratory (EMBL) and University Hospital Heidelberg, Heidelberg, Germany
10European Molecular Biology Lab (EMBL), Molecular Medicine Partnership Unit, Heidelberg, Germany

Ke Wang, PhD1*, Shayan Saniei1*, Nikita Poddar1*, Subrina Persaud1*, Meghana Sreenath1*, Miguel Quijada-álamo, PhD1*, Grace Freed1*, Anna Huo Chang Mei1*, Noshin Rahman1*, Jerry Chipuk1* and Elvin Wagenblast, PhD1,2,3

1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
2Department of Pediatrics, Division of Pediatric Hematology-Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
3Black Family Stem Cell Institute, Tisch Cancer Institute, Mindich Child Health & Development Institute, Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY

Mariam Hakobyan1,2,3*, Jens Langstein, Dr. rer. nat.1,4*, Emely Kleinert5*, Maximilian Schoenung, Dr. rer. nat.1,5*, Mark Hartmann, Dr. rer. nat.1*, Hannah Rohdjess, M.Sc.1,5*, Jessica Wojtarowicz, B.Sc.1,5*, Sina Staeble, Dr. rer. nat.1,6*, Rainer Claus, MD7*, Lars Bullinger8, Christopher C. Oakes, PhD9, Katharina Zoldan, Dr.10*, Michael Cross, Dr.10*, Uwe Platzbecker, MD11, Niclas Kneisel, Dr. rer. nat.12*, Simon Raffel, MD13*, Ulrich Germing, MD14*, Gregor Hoermann, PhD15*, Karsten Rippe, PhD16*, Stefan Fröhling, MD17,18,19*, Stefan Pusch, Dr. rer. nat.20*, Christoph Plass, Dr. rer. nat.21*, Michael D. Milsom, PhD22,23 and Daniel Lipka, MD1,5,24*

1NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, National Center for Tumor Diseases (NCT), Heidelberg, Germany
2Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, AL, Germany
3Faculty of Biosciences, Heidelberg University, Heidelberg, Germany
4NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, German Cancer Research Center, Heidelberg, Germany
5Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany
6Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany, German Cancer Research Center, Heidelberg, Germany
7Personalized Tumor Medicine and Molecular Oncology, University Hospital Augsburg, Augsburg, DEU
8Department of Hematology, Oncology, Tumor Immunology, Charité University Medicine, Berlin, Germany
9Division of Hematology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH
10Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Medical Center Leipzig, Leipzig, Germany
11Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
12SERVIER Germany, Munich, Germany
13Department of Medicine V, Universität Heidelberg, Heidelberg, Germany
14Department of Hematology, Oncology and Clinical Immunology, University Medical Center Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany
15MLL Munich Leukemia Laboratory, Munich, Germany
16German Cancer Research Center (DKFZ), Heidelberg, Germany
17Division of Translational Medical Oncology, National Center for Tumor Diseases, Heidelberg, Germany
18German Cancer Consortium (DKTK), Heidelberg, Germany
19Institute of Human Genetics, Heidelberg University, Heidelberg, Germany
20Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany
21Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
22The Heidelberg Institute for Stem Cell Technology and Experimental Medicine GmbH, Heidelberg, Germany
23Division of Experimental Hematology, German Cancer Research Center, Heidelberg, Germany
24Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany

Sarada Ketharnathan, PhD1, Keon Collett, BSc2*, Anna Pawelko3*, Benno Orr4*, Sergey V Prykhozhij, PhD1*, Martin Hirst, PhD, BSc5* and Jason N. Berman, MD1

1CHEO Research Institute, Ottawa, ON, Canada
2Cumming School of Medicine, University of Calgary, Calgary, Canada
3University of Ottawa, Ottawa, Canada
4Department of Molecular Genetics, University of Toronto, Toronto, Canada
5Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada

Michael E Lawler1*, Jennifer Romer-Seibert, PhD2*, Michael S Bowman, PhD3*, Ramkrishna Mitra, PhD2*, Christine Eischen, PhD2*, Robert L. Bowman, PhD3 and Sara E. Meyer, PhD2

1Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA
2Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, PA
3Department of Cancer Biology, University of Pennsylvania School of Medicine, Philadelphia, PA

Taishi Yonezawa, PhD1, Mikolaj Slabicki, PhD2*, Justine Rutter3*, Venkatasubramaniam Sundaramurthy, MS4,5, Gandhar Datar, BS1, Benjamin Levine Ebert, MD, PhD3,6,7,8,9 and Margaret Goodell, PhD4,10,11

1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX
2Massachusetts General Hospital Cancer Center, Boston, MA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston
5Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX
6Center for Prevention of Progression, Dana-Farber Cancer Institute, Boston, MA
7Broad Institute of MIT and Harvard, Cambridge
8Howard Hughes Medical Institute, Dana-Farber Cancer Institute, Boston
9Harvard Medical School, Boston, MA
10Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston
11Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX

Xiaoting Liang, Ph.D.1*, Yijie Zhai2*, Siqi Li, M.D.3*, Huiyun Peng, Ph.D.4*, Yun Huang5*, Youxin Feng5*, Tiebang Kang, Ph.D.6*, Yizhou Zou, Ph.D.7*, Xiao Jun Huang, M.D.3, Yingjun Chang, MD3* and Mi Deng, PhD1*

1Peking University International Cancer Institute, Peking University, Beijing, China
2Department of Immunology, School of Basic Medical Sciences, Health Science Center, Peking University, Beijing, China
3Department of Hematology, Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China
4Nanchang University, Nanchang, China
5Peking University Cancer Hospital & Institute, Beijing, China
6Sun Yat-Sen University Cancer Center, Guangzhou, China
7Department of Immunology, Xiangya School of Medicine, Central South University, Changsha, China

Jasmin Straube1,2*, Julian Grabek, MBBS, FRACP, FRCPA1,3*, Leanne Cooper3*, Rohit Haldar3*, Caroline McNamara, MBBS, FRACP, FRCPA4*, David M Ross, MD, PhD, FRACP, FRCPA5*, Andrew Charles Perkins, MBBS, PhD6, Megan Bywater, PhD1,3* and Steven W Lane, MBBS, PhD, FRCPA, FRACP1,4,7

1The University of Queensland, Brisbane, Australia
2Cancer Research Program, QIMR Berghofer, Brisbane, Australia
3Cancer Research Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia
4Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia
5Royal Adelaide Hospital, Adelaide, SA, Australia
6Australian Centre for Blood Diseases, Monash University, South Yarra, VIC, Australia
7Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia

Paniz Tavakoli, PhD1,2*, Megan Bywater, PhD1,2*, Jasmin Straube2,3*, Victoria Ling, MBBS, PhD1,2*, Emily Cooper1*, Rohit Haldar1*, Yashaswini Janardhanan1*, Leanne Cooper1*, Claudia Bruedigam, PhD1,2*, Carolyn S. Grove, MBBS, FRACP, FRCPA, PhD4 and Steven W Lane, MBBS, PhD, FRCPA, FRACP2,5,6

1Cancer Research Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia
2The University of Queensland, Brisbane, Australia
3Cancer Research Program, QIMR Berghofer, Brisbane, Australia
4School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia
5Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia
6Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia

Alessandra Hartke1,2*, Julia Klotz1,2*, Axel Künstner, PhD2,3*, Anke Fähnrich, PhD2,3*, Hauke Busch, PhD2,3*, Timo Gemoll, PhD2,4*, Jasmin Osius1,2*, Steffen Koschmieder, MD5,6, Tim H. H. Brummendorf, MD6,7, Heike L. Pahl, PhD8*, Florian H. Heidel, MD9, Konstanze Döhner, MD10, Martin Griesshammer, Prof. Dr. med.11, Andreas Reiter, MD12, Justus Duyster, MD13*, Nikolas C. C. von Bubnoff, Prof. Dr. med.1,2* and Sivahari P. Gorantla, PhD1,2*

1University Hospital Schleswig-Holstein, Department of Hematology and Oncology, Lübeck, Germany
2University Cancer Center Schleswig-Holstein, Lübeck, Germany
3Group for Medical Systems Biology, Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany
4University Hospital Schleswig-Holstein, Translationale Chirurgische Onkologie und Biomaterialbanken, Lübeck, Germany
5Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, RWTH Aachen University, Medical Faculty, Aachen, Germany
6Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany
7Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Medical Center Aachen, Aachen, Germany
8Universitätsklinikum Freiburg, Klinik für Hämatologie und Onkologie, Freiburg, Germany
9Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
10Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
11University Clinic for Hematology, Oncology, Hemostasis and Palliative Care, Johannes Wesling Medical Center, University of Bochum, Minden, Germany
12Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany
13University Hospital Freiburg, Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg, Germany

Christopher Peter Mill, PhD, BA1, Warren C. Fiskus, BSc, PhD2, Christine Birdwell, PhD1, John A. Davis1*, Kaberi Das, PhD2*, Hanxi Hou3*, Surbhi Sharma, PhD4, Koji Sasaki, MD5, Sanam Loghavi, MD6, Tapan M. Kadia, MD5, Naval Daver, MD1, Courtney D. DiNardo, MD, MSc7, Lu Wang8* and Kapil N. Bhalla, MD2

1MD Anderson Cancer Center, Houston, TX
2UT MD Anderson Cancer Center, Houston, TX
3The University of Texas MD Anderson Cancer Center, Houston, TX
4The UT MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
8Department of Biochemistry and Molecular Genetics, Northwestern University, Chicago, IL

César Alexander Ortiz Rojas, PhD1*, Diego A. Pereira-Martins, Ph.D.2,3,4*, Carol Thomé, PhD5*, Germano Ferreira, PhD6*, Thiago Mantello Bianco, Ph.D.7*, Isabel Weinhäuser, PhD8,9*, Cleide Lúcia Araújo Silva, PhD10*, Lorena Pontes11*, Vitor Faça, PhD5*, Emanuele Ammatuna, MD, PhD8*, Gerwin Huls3, Jan Jacob Schuringa, Prof. Dr.8 and Eduardo M. Rego, MD, PhD12

1Laboratório de Investigação Médica (LIM) 31, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, University of São Paulo, São Paulo, AL, Brazil
2Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, University of São Paulo Medical School, São Paulo, Brazil
3Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, Groningen, Netherlands
4Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University Medical Center Groningen, Groningen, Netherlands
5Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, São Paulo, Brazil, São Paulo, Brazil
6Medical School of Ribeirao Preto, University of São Paulo, Ribeirão Preto, BRA
7Department of Medical Images, Haematology, and Clinical Oncology, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil
8Department of Experimental Hematology, University Medical Center Groningen, Groningen, Netherlands
9Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom
10Blood Center of Ribeirao Preto, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil., Ribeirão Preto, Brazil
114Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil
12Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, University of São Paulo Medical School, Sao Paulo, Brazil

Maximilian Holz1,2*, Bertram Klinger3,4*, Felix Stuckenbrok1,5,6*, Stefanos A. Bamopoulos, MD7,8*, Sanket Gosavi5*, Caroline Bräuning9*, Janine Altmüller9*, Roland Rad10*, Torsten Haferlach, MD6, Nils Blüthgen11,12*, Ulrich Keller13,14,15,16*, Thomas Conrad17* and Francis Baumgartner1,5,6,12*

1Max-Delbrück-Center for Molecular Medicine, Berlin, Germany
2Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité, Berlin, DEU
3Institute of Pathology, Charité-Universitätsmedizin Berlin, Berlin, Germany
4Institute for Theoretical Biology, Humboldt-Universität zu Berlin, Berlin, Germany
5Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany
6MLL Munich Leukemia Laboratory, Munich, Germany
7Max-Delbrück-Center for Molecular Medicine,, Berlin, Germany
8Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité University Medicine Berlin, Berlin, DEU
9Genomics Technology Platform, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
10Institute of Molecular Oncology and Functional Genomics, Technical University of Munich, Munich, Germany
11Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
12German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Berlin, Germany
13German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
14Max-Delbrück-Center, Berlin, Germany
15Hematology, Oncology and Cancer Immunology, Charité - University Medical Center Berlin, Campus Benjamin Franklin, Berlin, Germany
16German Cancer Consortium (DKTK) partner site Berlin, a partnership between DKFZ and Charité – Universitätsmedizin Berlin, Berlin, Germany
17Genomics Technology Platform, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, DEU

Rebecca Voss, MD1*, Wenqing Qi1*, Yen-Chun Liu, MD, PhD2*, Jing Ma, PhD3*, La'Ron Browne, MBBS, MSc1*, Mahsa Khanlari, MD1, Juan M Barajas, PhD3, Melvin Thomas III, PhD4, Victor B Pastor Loyola, PhD2*, Hui Cao5*, Seth E. Karol, MD6, Jeffrey E. Rubnitz, MD, PhD7, Jeffery M Klco, MD, PhD3 and Lu Wang, MD, PhD2*

1St. Jude Children's Research Hospital, Memphis, TN
2Department of Pathology, St. Jude Children's Research Hospital, Memphis
3Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
4St. Jude Children's Research Hospital, Bartlett, TN
5St. Jude Children's Research Hospital, Memphist, TN
6Department of Oncology, St Jude Children's Research Hospital, Memphis, TN
7Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

Pia Christin Radszuweit1,2*, Barbara Mankel3*, Fulya Korkmaz2*, Hildegard Keppeler2*, Claudia Lengerke, MD4, Dominik Schneidawind1,2* and Corina Schneidawind, MD, PhD1,2*

1Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
2Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
3Institute of Pathologie, Tübingen, DEU
4Department for Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany

Lingli He, PhD1,2,3*, Ting Zhao, PhD2*, Wei Zhong Leong, Ph.D.1*, Azeem Sharda1*, Christina Mayerhofer, MD2*, Shenglin Mei, PhD2*, Gracia M. Bonilla, PhD4*, Juan Bautista Menendez-Gonzalez, PhD1*, Karin Gustafsson, PhD2*, Tsuyoshi Fukushima, MD, PhD2*, Trine A. Kristiansen, PhD2*, Ji-Won Lee, PhD2*, Yanxin Xu, PhD2*, Bogdan Budnik, PhD5*, Ruslan Sadreyev, PhD4*, Zhixun Dou, PhD2*, David B. Sykes, MD, PhD2 and David Scadden, MD1,2,3

1Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA
2Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA
3Harvard Stem Cell Institute, Cambridge, MA
4Department of Molecular Biology, Massachusetts General Hospital, Boston, MA
5Mass Spectrometry and Proteomics Research Laboratory, Harvard University, Cambridge, MA

Lu Zhang1*, Xuefeng Wang2,3*, Dongmei Hu4*, Shijie Li4*, Mingshan Sun4*, Qian Liu4*, Huimin Feng4*, Minran Zhou4*, Chen Chunyan, MD4, Huan Zhou2,3* and Sai Ma4*

1Department of Hematology, Qilu Hospital of Shandong University, Jinan, AL, China
2National Drug Clinical Trial Institution, the First Affiliated Hospital of Bengbu Medical University, Bengbu, China
3Key Laboratory of Innovative Drug Pharmaceutical Research and Clinical Evaluation Jointly Established Disciplines in Anhui Province, Hefei, China
4Department of Hematology, Qilu Hospital of Shandong University, Jinan, China

Xuefei Ma, MS1,2*, Weifen Sun, PhD3*, Yilu Li, PhD3*, Yun Tan, PhD3, Xuefeng Wang, MD, PhD2* and Kankan Wang, MD, PhD4*

1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Ruijin Hospital, Shanghai, China
2Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
4Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

*signifies non-member of ASH